Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
bio
2
×
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
approval
apremilast
base editing
biogen
biome
biotech
blueprint medicineas
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
briefing docs
california
cancer
car-t
celgene
cervical cancer
clinical study
clinical trial
commissioner
crispr
crispr therapeutics
cybersecurity
democrats
detection
detroit blog main
detroit top stories
digital health
disease
diversity
donald trump
endpoints
fail
What
cancer
million
remains
2
×
years
according
allogene
attacks
bio
bioscience
counterpoint
crispr
diagnosis
died
disease
diversity
globally
health
history
hot
human
immunotherapy
initial
investors
ipo
juno
march
medical
nearly
new
organization
people
physiology
progress
received
roundup
scored
shares
snapped
therapeutics
ticket
Language
Current search:
remains
×
bio
×
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@techcrunch.com
6 years ago
Tradewind Bioscience attacks the physiology of tumors to treat cancer
